Yatharth Hospital & Trauma Care Services Limited has reported a robust financial performance for the second quarter of fiscal year 2026, with significant growth in revenue and profitability.

Key Financial Highlights

• Revenue: The company's revenue from operations surged by 28% year-over-year to Rs 2,794.00 million in Q2 FY26, up from Rs 2,178.00 million in Q2 FY25.
• EBITDA: Earnings Before Interest, Tax, Depreciation, and Amortization (EBITDA) grew by 18% to Rs 645.00 million, compared to Rs 546.00 million in the same quarter last year.
• PAT: Profit After Tax (PAT) increased by 33% to Rs 413.00 million, up from Rs 310.00 million in Q2 FY25.

Operational Performance

Yatharth Hospital demonstrated strong operational metrics during the quarter:

• Bed Capacity: The total bed capacity stood at 2,305 beds, excluding the upcoming 250-bed Agra hospital.
• Occupancy: The company maintained a healthy occupancy rate of 66%.
• ARPOB: Average Revenue Per Occupied Bed (ARPOB) improved to Rs 32,015.00, indicating enhanced revenue generation per patient.

Expansion and Growth

The company continues to expand its presence and diversify its revenue streams:

• Yatharth Hospital acquired a new 250-bed facility in Agra, further strengthening its footprint in North India.
• The Greater Faridabad hospital, which commenced operations recently, now contributes 10% to the group's revenue in Q2 FY26.
• The company's mature hospitals (Noida, Greater Noida, and Noida Extension) sustained an upward trajectory with 19% year-on-year growth.

Strategic Initiatives

Yatharth Hospital is focusing on several strategic initiatives to drive growth:

• Strengthening its governance framework by appointing MSKA & Associates (a member firm of BDO International) as the statutory auditor.
• Expanding its presence in high-value specialties across hospitals, with a diverse mix of specialties at all facilities.
• Continuing to invest in infrastructure and technology to enhance clinical excellence.

Future Outlook

With its strategic expansions and focus on high-value specialties, Yatharth Hospital & Trauma Care Services Limited appears well-positioned for continued growth. The company's ability to maintain strong occupancy rates and improve ARPOB suggests a positive outlook for the coming quarters.

Investors and stakeholders may keep a close eye on the integration of new facilities and the ramp-up of recently acquired hospitals, as these factors could influence the company's future performance and profitability.

Yatharth Hospital & Trauma Care Services Limited has announced its financial results for the second quarter of fiscal year 2026, showcasing robust growth across key metrics.

Financial Highlights

Revenue Growth

The company reported a consolidated revenue of Rs 2,794 million for Q2 FY26, marking a significant 28% increase from Rs 2,178 million in the same quarter of the previous fiscal year. This substantial growth in revenue indicates strong operational performance and increased patient footfall.

Profitability

Yatharth Hospital's consolidated net profit saw an impressive rise of 33%, reaching Rs 413 million in Q2 FY26, up from Rs 310 million in Q2 FY25. This notable increase in profitability demonstrates the company's ability to effectively manage costs while expanding its operations.

EBITDA Performance

The company's EBITDA (Earnings Before Interest, Taxes, Depreciation, and Amortization) grew by 18% year-over-year, rising from Rs 546 million in Q2 FY25 to Rs 645 million in Q2 FY26. However, the EBITDA margin experienced a slight decline, moving from 25.1% to 23.1%, a decrease of 200 basis points.

Half-Yearly Performance

For the first half of FY26, Yatharth Hospital reported equally impressive results:

• Revenue increased by 25% to Rs 5,372 million
• EBITDA grew by 19% to Rs 1,290 million
• Profit After Tax surged by 36% to Rs 833 million

These results underscore the company's consistent growth trajectory and operational efficiency over a broader timeframe.

The strong financial performance of Yatharth Hospital & Trauma Care Services Limited in Q2 FY26 reflects its expanding market presence and effective management strategies. While the company has shown remarkable growth in revenue and profitability, the slight decrease in EBITDA margin may warrant attention in future quarters to ensure sustained financial health.